亚视觉影像信号可作为即将发生肺转移的生物标志物:一项多中心泛癌研究
该多中心研究纳入乳腺癌、结直肠癌和食管癌患者,基于至少三次随访胸部CT提取三维肺感兴趣区的信号特征,采用多时间点建模开发机器学习模型。信号阳性患者的实际肺转移风险显著高于信号阴性患者,提前时间分别为乳腺癌0.84年、结直肠癌1.41年、食管癌0.83年。亚视觉胸部CT信号可作为跨癌种即将发生肺转移的生物标志物。
要点
- 信号阳性患者肺转移风险显著高于信号阴性:乳腺癌57.14% vs 5.77%,结直肠癌66.67% vs 6.25%,食管癌50.00% vs 12.50%。
- 从首次信号阳性到发生转移的提前时间:乳腺癌0.84年、结直肠癌1.41年、食管癌0.83年。
- 模型应用建议至少两次CT扫描:乳腺癌/结直肠癌在1.5年内,食管癌在0.5年内。
核心结论
- 亚视觉胸部CT信号可作为跨癌种检测即将发生肺转移的生物标志物。
- 该无创方法可动态识别高风险患者,为早期干预提供可能。
研究设计与样本
- 多中心研究,纳入来自四家医院的乳腺癌、结直肠癌和食管癌患者,每位患者至少三次随访胸部CT。
- 从三维肺感兴趣区提取信号特征,采用多时间点建模方法分析各时间点特征以开发机器学习模型,以曲线下面积评估性能。
- 研究分析了2148例癌症患者的10280次随访胸部CT扫描。
主要发现
- 信号阳性患者实际肺转移风险显著高于信号阴性患者:乳腺癌57.14% vs 5.77%(校正p < 0.0001)。
- 结直肠癌信号阳性 vs 阴性肺转移风险为66.67% vs 6.25%(校正p = 0.0361)。
- 食管癌信号阳性 vs 阴性肺转移风险为50.00% vs 12.50%(校正p = 0.0480)。
- 从首次信号阳性到发生转移的提前时间:乳腺癌0.84年、结直肠癌1.41年、食管癌0.83年。
关键数值与推荐
- 采用预设截断值将患者分类为信号阳性或信号阴性。
- 模型应用建议至少两次CT扫描:乳腺癌/结直肠癌在1.5年内,食管癌在0.5年内。
临床怎么用
- 对于乳腺癌、结直肠癌和食管癌患者,可利用系列胸部CT的亚视觉信号动态识别肺转移高风险人群。
- 根据推荐的时间间隔进行CT随访以满足模型应用所需的扫描次数。
- 信号阳性患者可考虑提前进行临床干预或密切监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY AIM: Early detection of distant metastases is crucial, but current imaging detects them only when radiographically visible. This study reported subvisual chest CT signals could serve as early biomarkers for impending lung metastasis before radiological visibility. METHODS: This multicenter study enrolled breast, colorectal, and esophageal cancer patients from four hospitals, with at least three follow-up chest CT scans per patient. Signaling features were extracted from 3D lung regions of interest (ROIs). Using Multi-TimePoint Modeling approach, we analyzed features across time points to develop machine learning models, with performance evaluated by the area under the curve. A predefined cutoff classified patients as Signal-Positive or Signal-Negative, and the actual lung metastasis risk was compared between these groups. The lead time that spanned from first Signal-Positivity to metastasis, and the impact of CT scan count and interval on model performance were explored. RESULTS: This study analyzed 10,280 follow-up chest CT scans from 2148 cancer patients. Signal-Positive patients showed significantly higher actual lung metastasis risk than Signal-Negative patients: 57.14 % vs 5.77 % (breast, adjusted p < 0.0001), 66.67 % vs 6.25 % (colorectal, adjusted p = 0.0361), and 50.00 % vs 12.50 % (esophageal, adjusted p = 0.0480). The lead times were 0.84 years (breast), 1.41 years (colorectal), and 0.83 years (esophageal). At least two CT scans within 1.5 years (breast/colorectal cancer) or 0.5 years (esophageal cancer) are recommended for model application. CONCLUSION: Subvisual chest CT signals serve as biomarkers for impending lung metastasis detection across cancers. This non-invasive approach dynamically identifies high-risk patients, enabling possible early intervention.
引用
- Zhang R, Li H, Ding L, et al. Subvisual imaging signals as biomarkers of impending lung metastasis: A multicenter pan-cancer study. Eur J Cancer. 2025. PMID: 41129982. doi:10.1016/j.ejca.2025.116056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。